Page 110 - Genentech News Today

First subcutaneous anti-PD-1 cancer immunotherapy available to patients in Great Britain Tecentriq® subcutaneous formulation with ENHANZE® reduces treatment time to seven minutes compared to...

The Biden administration has released a list of 10 prescription drugs that will be subject to the first-ever price negotiations by the US Medicare health program.The list includes:Eliquis, a blood...

Britains state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three...

It is already changing how pharma companies make drugs

Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England said on Tuesday hundreds of eligible patients treated with the immunotherapy, atezolizumab, were set to have "under the skin" injection, which will free up more time for cancer teams. "This approval will not only allow us to deliver convenient and faster care for our patients, but will enable our teams to treat more patients throughout the day," Dr Alexander Martin, a consulta...

It is already changing how pharma companies make drugs | Business

Britain's state-run National Health Service will be the first in the world to offer an injection that treats...

Britain's state-run National Health Service will be the first in the world to offer an injection that treats...

Britain's state-run National Health Service will be the first in the world to offer an injection that treats...

Appointment of industry veterans, Dr. Hans-Peter Gerber, PhD, as Chairman and Dr. Bernd Eschgfäller, PhD, as independent Board member.Strengthens T-CURX’s Board to accelerate the commercialization of its proprietary CAR-T technologies and CAR-T pipeline programs.WÜRZBURG, Germany, August 28, 2023 / B3C new...